A Predictive Model for Toxicity Effects Assessment of Biotransformed Hepatic Drugs Using Iterative Sampling Method.

Alaa Tharwat, Yasmine S Moemen, Aboul Ella Hassanien
Author Information
  1. Alaa Tharwat: Faculty of Engineering, Suez Canal University, Egypt.
  2. Yasmine S Moemen: Scientific Research Group in Egypt, (SRGE), Cairo, Egypt.
  3. Aboul Ella Hassanien: Scientific Research Group in Egypt, (SRGE), Cairo, Egypt.

Abstract

Measuring toxicity is one of the main steps in drug development. Hence, there is a high demand for computational models to predict the toxicity effects of the potential drugs. In this study, we used a dataset, which consists of four toxicity effects:mutagenic, tumorigenic, irritant and reproductive effects. The proposed model consists of three phases. In the first phase, rough set-based methods are used to select the most discriminative features for reducing the classification time and improving the classification performance. Due to the imbalanced class distribution, in the second phase, different sampling methods such as Random Under-Sampling, Random Over-Sampling and Synthetic Minority Oversampling Technique are used to solve the problem of imbalanced datasets. ITerative Sampling (ITS) method is proposed to avoid the limitations of those methods. ITS method has two steps. The first step (sampling step) iteratively modifies the prior distribution of the minority and majority classes. In the second step, a data cleaning method is used to remove the overlapping that is produced from the first step. In the third phase, Bagging classifier is used to classify an unknown drug into toxic or non-toxic. The experimental results proved that the proposed model performed well in classifying the unknown samples according to all toxic effects in the imbalanced datasets.

References

  1. Anal Chim Acta. 2011 Apr 29;692(1-2):50-6 [PMID: 21501711]
  2. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72 [PMID: 16381955]
  3. J Proteome Res. 2007 Nov;6(11):4407-22 [PMID: 17915905]
  4. Comput Methods Programs Biomed. 2014;113(1):175-85 [PMID: 24210167]
  5. J Chem Inf Model. 2015 Feb 23;55(2):460-73 [PMID: 25558886]
  6. Toxicol Lett. 1995 Sep;79(1-3):219-28 [PMID: 7570659]
  7. J Chem Inf Model. 2006 Mar-Apr;46(2):536-44 [PMID: 16562981]
  8. Toxicol Sci. 2009 Dec;112(2):385-93 [PMID: 19805409]
  9. Nat Rev Drug Discov. 2002 Jan;1(1):84-8 [PMID: 12119613]
  10. Environ Mol Mutagen. 2001;37(1):55-69 [PMID: 11170242]
  11. J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):1947-58 [PMID: 14632445]
  12. Nat Rev Drug Discov. 2003 Jul;2(7):542-53 [PMID: 12815380]

MeSH Term

Algorithms
Drug-Related Side Effects and Adverse Reactions
Humans
Inactivation, Metabolic
Liver
Models, Biological
ROC Curve
Reproducibility of Results

Word Cloud

Created with Highcharts 10.0.0usedsteptoxicityeffectsproposedfirstphasemethodsimbalancedmethodstepsdrugconsistsmodelclassificationdistributionsecondsamplingRandomdatasetsSamplingITSunknowntoxicMeasuringonemaindevelopmentHencehighdemandcomputationalmodelspredictpotentialdrugsstudydatasetfoureffects:mutagenictumorigenicirritantreproductivethreephasesroughset-basedselectdiscriminativefeaturesreducingtimeimprovingperformanceDueclassdifferentUnder-SamplingOver-SamplingSyntheticMinorityOversamplingTechniquesolveproblemITerativeavoidlimitationstwoiterativelymodifiespriorminoritymajorityclassesdatacleaningremoveoverlappingproducedthirdBaggingclassifierclassifynon-toxicexperimentalresultsprovedperformedwellclassifyingsamplesaccordingPredictiveModelToxicityEffectsAssessmentBiotransformedHepaticDrugsUsingIterativeMethod

Similar Articles

Cited By